Skip to main content
Clinical Trials/EUCTR2005-001341-42-DK
EUCTR2005-001341-42-DKActive, not recruitingPhase 1

Treatment strategy in adrenocortical carcinomasFase II trial with docetaxel and cisplatin in patients with locally advanced or disseminated adrenocortical carcinomas

Rigshospitalet0 sites39 target enrollmentStarted: February 10, 2006Last updated:
Drugs

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Enrollment
39

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Adrenocortical carcinoma
  • no possibility for operation
  • age > 18 years
  • performance 0 or 1
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • performance 2 or less
  • other cancer diseases

Investigators

Similar Trials